The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Adult T Cell Leukemia Lymphoma

HTLV 1 driven mature T cell malignancy with diverse clinical subtypes

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Hematoloji department. Book Appointment →

What is Adult T Cell Leukemia Lymphoma?

Adult T cell leukemia lymphoma is a peripheral mature T cell neoplasm driven by clonal integration of human T lymphotropic virus type 1 acquired through breastfeeding, sexual contact, or transfusion. Endemic regions include southwestern Japan, the Caribbean basin, parts of Africa, South America, and Iran with a long latency between infection and overt disease.

Shimoyama subtypes guide therapy: acute presents with leukemic phase, hypercalcemia, and skin lesions; lymphomatous mimics aggressive lymphoma without leukemic involvement; chronic shows lymphocytosis with skin disease and may have favorable variant; smoldering shows minimal leukemic burden with cutaneous or pulmonary lesions. Flower cells in blood and abnormal CD4 positive CD25 high cells are characteristic.

Treatment differs by subtype: acute and lymphomatous receive intensive chemotherapy such as VCAP AMP VECP or interferon plus zidovudine; chronic and smoldering may follow watch and wait or antiviral therapy; allogeneic transplantation offers cure in selected aggressive cases. Mogamulizumab is approved for relapsed disease with anti CCR4 activity.

Symptoms

Skin nodules and erythematous patches
Generalized lymphadenopathy
Hypercalcemia with confusion
Hepatosplenomegaly with leukemic cells
Opportunistic infections from immunosuppression

Risk Factors

Origin in HTLV 1 endemic region
Vertical transmission via breastfeeding
Sexual transmission of HTLV 1
Transfusion exposure decades earlier
Long latency from initial infection

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • When persistent skin lesions occur in HTLV 1 carrier
  • When unexplained lymphadenopathy develops
  • When hypercalcemia presents with lymphocytosis
  • When opportunistic infections appear
  • When subtype determination is needed

Treatment Methods

01
Subtype based Shimoyama classification
02
Interferon alpha and zidovudine combination
03
Intensive chemotherapy for aggressive subtypes
04
Mogamulizumab for relapsed disease
05
Allogeneic transplantation for fit patients
06
Watch and wait for indolent variants
07
Hypercalcemia management with bisphosphonates

Which Department to Visit?

You can visit our Hematoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Hematoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.